Gene Therapy could Change the Goalpost in Sickle Cell Disease
While worthy advances have recently been made in sickle cell disease, companies such as Graphite Bio, bluebird bio, Vertex Pharmaceuticals and Editas Medicine have loftier ambitions.
Source: biospace.com